Activating mutations in the CSF1R, encoding the colony-stimulating factor 1 receptor, have been identified in histiocytic neoplasms, suggesting a role in disease development and potential therapeutic targeting [18, 40, 41]. This evidence concerns the gene CSF1R and histiocytic neoplasm.